| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.86B | +42.9% |
| Cost of Revenue | $546.0M | +37.7% |
| Gross Profit | $1.31B | +45.2% |
| R&D Expense | $620.0M | +32.1% |
| SG&A Expense | $409.0M | -5.2% |
| Operating Income | -$812.0M | -5.9% |
| Interest Expense | $11.0M | -88.1% |
| Pre-tax Income | -$801.0M | +5.7% |
| Income Tax | $14.0M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $264.0M | +1.5% |
| Short-term Investments | $2.32B | +3.3% |
| Accounts Receivable | $481.0M | +21.0% |
| Current Assets | $3.23B | +6.2% |
| Total Assets | $9.31B | +1.1% |
| Current Liabilities | $1.47B | +17.9% |
| Total Liabilities | $3.84B | +17.0% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $86.0M | -17.4% |
| Capital Expenditures | $12.0M | -2.5% |
| Investing Cash Flow | -$130.0M | +64.6% |
| Financing Cash Flow | $48.0M | -46.1% |
| Free Cash Flow | $74.0M | -19.4% |
| +1189.5% |
| Net Income | -$815.0M | +3.9% |
| EPS (Basic) | -$5.16 | +9.9% |
| EPS (Diluted) | -$5.16 | +9.9% |
| Stockholders' Equity |
| $5.47B |
| -7.7% |